Comparing Peginterferon Alfa-2a vs Ruxolitinib
| Peginterferon alfa-2a | Ruxolitinib |
|
|---|
| Peginterferon alfa-2a | Ruxolitinib |
|
|---|---|---|
|
Prescription only
Prescribed for Polycythemia Vera, Hepatitis C, Thrombocythemia, Hepatitis B. Peginterferon alfa-2a may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Myelofibrosis, Polycythemia Vera, Graft Versus Host Disease, Myeloproliferative Disorders. Ruxolitinib may also be used for purposes not listed in this medication guide. |
Related suggestions Polycythemia Vera
|
| More about Peginterferon alfa-2a | More about Ruxolitinib | |
| Ratings & Reviews | ||
|
Peginterferon alfa-2a has an average rating of 7.3 out of 10 from a total of 19 ratings on Drugs.com. 58% of reviewers reported a positive effect, while 16% reported a negative effect. |
Ruxolitinib has an average rating of 7.3 out of 10 from a total of 43 ratings on Drugs.com. 65% of reviewers reported a positive effect, while 16% reported a negative effect. |
|
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||
|
View all Peginterferon alfa-2a side effects |
View all Ruxolitinib side effects |
|
| Drug Class | ||
| Generic Availability | ||
|
N/A |
N/A |
|
| Pricing and Coupons * Prices are without insurance | ||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
|
| Dosage Forms | ||
|
N/A |
N/A |
|
| Brand Names | ||
| Pegasys | Jakafi | |
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||
|
140 hours |
5.8 hours |
|
| CSA Schedule 1 View glossary of CSA terms | ||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
|
| Pregnancy Category | ||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
|
| Drug Interactions | ||
|
A total of 229 drugs are known to interact with Peginterferon alfa-2a:
|
A total of 510 drugs are known to interact with Ruxolitinib:
|
|
| Alcohol/Food/Lifestyle Interactions | ||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
|
| Disease Interactions | ||
| First Approval Date | ||
|
N/A |
November 16, 2011 |
|
| WADA Class View classifications | ||
|
N/A |
N/A |
|
| More Information | ||
| Patient Resources | ||
| Professional Resources | ||
|
N/A |
||
| Related Treatment Guide | ||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Epclusa
Epclusa treats chronic hepatitis C in adults and children 3+. This once-daily antiviral combines ...
Vemlidy
Vemlidy (tenofovir alafenamide) is an oral, once-daily, antiviral tablet that may be used to treat ...
Amvuttra
Amvuttra is used to treat polyneuropathy associated with hereditary transthyretin-mediated ...
Harvoni
Harvoni is used to treat hepatitis C virus (HCV) infections in adults and children aged 3 years and ...
Mavyret
Mavyret (glecaprevir/pibrentasvir) is an oral combination medicine containing fixed doses of two ...
Viread
Viread (tenofovir) is used to treat HIV, which causes the acquired immunodeficiency syndrome ...
Baraclude
Baraclude (entecavir) is and antiviral medicine used to treat chronic hepatitis B. Includes ...
Sovaldi
Sovaldi (sofosbuvir) is used to treat chronic hepatitis C virus (HCV) infection. Includes Sovaldi ...
Epivir
Epivir (lamivudine) is used to treat HIV, which causes the acquired immunodeficiency syndrome ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.